Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Amo... ( -- Oct. 18 10 am to 4 pm JWCH Institu...)

Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos

Date:10/13/2008

-- Oct. 18, 10 am to 4 pm, JWCH Institute, Men's Central Jail Health Fair, 441 Bauchet Street, Los Angeles, 90012

-- For full list of events and for more information, please visit NLAAD-LA.org or HIVLA.org

INTERVIEW OPPORTUNITIES

Our Community, Our Responsibility: Latinos in Action -- media invited at 8:30 am
-- Mario J. Perez, Director, Office of AIDS Programs and Policy

-- Richard Zaldivar, Executive Director, The Wall Las Memorias

-- Paulina Zamudio, Manager, Prevention Services Division, Office of AIDS

Programs and Policy

-- Latino AIDS activists and HIV/AIDS service providers

BACKGROUND: NLAAD began in 2003 as a creation of the Latino Commission on AIDS and the Hispanic Federation in partnership with a variety of local faith and community groups. This year's event planning was conducted by Los Angeles HIV/AIDS community-based organizations and endorsed by the County of Los Angeles, Department of Public Health's Office of AIDS Programs and Policy.

SOURCE County of Los Angeles, Department of Public Health Officeof AIDS
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
2. Nearly 30 Percent of Realtors(R) Lack Health Insurance
3. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
4. New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
5. Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
6. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
7. Smokers Cost Medicaid System Nearly $10 Billion
8. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
9. Cipla Offers Modest AIDS Drug Price Cut: Not Nearly Enough, says AHF
10. Metabolic syndrome affects nearly 1 in 10 US teens
11. Eleven Florida Nonprofit Organizations to Receive Grants Totaling Nearly $1 Million From The Blue Foundation

Post Your Comments:

(Date:12/5/2009)...a Cause ,, Why: To make a difference in the fig...ecting children. All proceeds from each hair servi...search Hospital. Guests will enjoy complimentary b...ers, a delectable and savory Vietnamese restaurant...wn for creating fun and unique mixes will be spinn...

(Date:12/5/2009)...yeloproliferative disorders are serious and often ...the 51st Annual Meeting of the American Society of...ions and improved diagnostic methods for patients ...ic myeloid leukemia, infant acute lymphoblastic le...er understanding of the underlying genetic causes ...

(Date:12/5/2009)...Technology Center helps companies develop and test...e to the lab allows it to work in a variety of ind...to cleaning parts, process development, and verifi...r 5, 2009 -- Midbrook, Inc , a Jackson, MI-based ...laboratory that performs a wide variety of tasks f...

(Date:12/5/2009)...pping up in the most unusual places, and to do eve...ping prisoners in jail! , ...t that your wine, water and vegetables would have ...Texas has announced a new line of turbines, for in...logy developed to provide power for dairies in Hol...

(Date:12/4/2009)...P employees came together in more than 90 offices ...rvice event which combines the audit, tax and advi...iving. ,, "This national service day reflects our...oliday parties, our employees gathered in the spir...ldren," said Tim Flynn, Chairman of KPMG. ,, ,O...

[0] Salon Leau to Host 'Cuts for a Cause' to Raise Funds and Spread the Word About Childhood Terminal Illnesses [0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children

..., N.J., Dec. 24 QMed, Inc., (Nasdaq:,QMED) today ...q indicating,that for the last 30 business days, t...sed below the minimum $1.00 per share requirement ...ll be provided 180 calendar days, or until June 16...

... to relax and keep hassles in perspective, experts...s) -- It,s supposed to be the happiest time of the... the offices of San Diego cardiologist Dr. Mimi Gu... to stress or overindulgence. Others feel physical...

... Md., Dec. 24 /Xinhua-PRNewswire/ -- Chindex Inter...rican provider of Western healthcare,services and ...ced today it,has received approval from NASDAQ for...een completed and trading will,commence today. The...

...LLE, Pa., Dec. 24 Wyeth,Pharmaceuticals, a divisi...e,U.S. Food and Drug Administration (FDA) has issu...selective estrogen receptor modulator, for the,pre...tified during the review process and,that were not...

...H, Fla., Dec. 24 Veterans Affairs Medical,Center ... could help reduce,the spiraling cost of healthcar... in the area to adopt a privacy,curtain for hospit...could save maintenance personnel many hours it,tak...

...Dec. 24 /PRNewswire-FirstCall/ - Transition Therap...TTH; NASDAQ: TTHI), announced today,that the Compa...der its,global collaboration agreement with a subs...,s disease drug candidate, ELND005,(AZD-103), whic...

Other Medicine News:Health News:QMed, Inc. Receives NASDAQ Letter 2 Health News:'Easy Does It' Eases Holiday Stress 2 Health News:Chindex International, Inc. Announces Transfer to NASDAQ Global Market 2 Health News:Chindex International, Inc. Announces Transfer to NASDAQ Global Market 3 Health News:Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 2 Health News:Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 3 Health News:VA Hospital Draws Curtain on Innovation That Could Help Reduce Spiraling Cost of Hospital Maintenance Nationwide 2 Health News:Transition Therapeutics Announces Milestone Payment from Elan 2

QMed, Inc. Receives NASDAQ Letter 'Easy Does It' Eases Holiday Stress Chindex International, Inc. Announces Transfer to NASDAQ Global Market Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis VA Hospital Draws Curtain on Innovation That Could Help Reduce Spiraling Cost of Hospital Maintenance Nationwide Transition Therapeutics Announces Milestone Payment from Elan

(Date:12/3/2009)... , DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Ch...: QGLY ) www.quigleyco.com announced today that...pportunities to develop prescription pharmaceutica... its best interests to focus primarily on the OTC/...re not limited to its Cold-EEZE® and Kids-EEZ...

(Date:12/3/2009)... , WILMINGTON, Del., Dec. 3 ParagonRx, a Del... risk management and optimal medication use, will ...DA,s draft guidance on REMS - Risk Evaluation Miti...r REMS lifecycle management. Dr. Gary Slatko, chi...EMS and risk management programs, will lead the on...

(Date:12/3/2009)... , DURHAM, N.C., Dec. 3 In response to the inc...technologies in the evolving healthcare delivery s...or Health Informatics (DCHI) to provide a campus f...innovative interdisciplinary approach to education... nurses and healthcare administrators with an expe...

Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2 Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3 Duke Medicine to Train Healthcare Professionals in Health Informatics 2 Duke Medicine to Train Healthcare Professionals in Health Informatics 3 deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 1 deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 2 deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 3 deCODE Discovers Four New Risk Factors for Prostate Cancer 5020 4 Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health 57713 1 Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health 57713 2 Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 1 Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 2 Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 3 Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 57710 4

[0] Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution [0] Webinar to Explore FDA Draft REMS Guidance and Its Implications for Lifecycle Management [0] Duke Medicine to Train Healthcare Professionals in Health Informatics

...INESS WIRE)--Jul 6, 2007 - Cobalis Corp.,(OTCBB:CL...zing in,anti-allergy medications, today reported p...nical trials for its drug,PreHistin(TM) in patient...rgic rhinitis, commonly known as hay fever. The tr...o and,PreHistin-treated patient groups, thereby le...

...NESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals,Inc...Glycoscience(R)", today updated the progress of it... of metastatic, unresectable,colorectal cancer pat... oxaliplatin, and its Phase II clinical trial for ...reatment for both,indications may represent orphan...

Other Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2 Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3 Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4 Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5

Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings

...y method for the semi-quantitative determination o...serum. The results of the anti-Gliadin IgA assay c...associated with elevated levels of anti-Gliadin an...e autoantibodies are one indicator in a multi-fact...

Free Estriol ELISA

...oper work area solution to manage your daily urina...,The progressive semi-automated Urisys 1800 analy...supported by optional barcode reader and sediment ...s analysis while high quality chemistries provide ...

...e immunoassay (EIA) test kit is to be used for the... human serum during the second half of pregnancy. ...procedure is an enzyme immunoassay which is based ...rocedure, estriol is conjugated to alkaline phosph...

Medicine Products:

AUTOSTAT™II Anti-Gliadin IgA ELISA Free Estriol ELISA Urisys 1800 Estriol (Unconjugated) Enzyme Immunoassay Test Kit

Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Amo...( -- Oct. 18 10 am to 4 pm JWCH Institu...),Health